Head-to-head comparisons of medication uses, side effects, warnings, and more.
Tremfya (guselkumab)
Skyrizi (risankizumab)
Tremfya (guselkumab)
Skyrizi (risankizumab)
Summary of Tremfya vs. Skyrizi
Summary for Interleukin antagonist
Prescription only
Tremfya (guselkumab) is an injection for adults with certain inflammatory conditions. It helps treat plaque psoriasis, psoriatic arthritis, ulcerative colitis, and Crohn's disease. Tremfya (guselkumab) is a monoclonal antibody known as an interleukin antagonist. It calms your immune system to lower inflammation. The dosing schedule is every 1 or 2 months, depending on your condition and how far along you are in treatment. Side effects are upper respiratory infections, headache, and injection site reactions. There's also a risk of other infections and liver problems as long-term side effects.